John C. Moore

Coherent, Inc. is a provider of laser solutions and optics for microelectronics, life sciences, industrial manufacturing, scientific and aerospace, and defense markets. It operates through the following business segments: OEM Laser Sources (OLS) and Industrial Lasers & Systems (ILS). The OLS segment focuses on laser sources and complex optical sub-systems, typically used in microelectronics manufacturing, medical diagnostics, and therapeutic medical applications. The ILS segment covers laser sources, sub-systems, and tools, which are used for industrial laser materials processing. The company was founded by Eugene Watson on May 26, 1966, and is headquartered in Santa Clara, CA.

Optovue, Inc. develops ophthalmic diagnosis instruments based on the Fourier-Domain OCT technology. Its products include Avanti, RTVue Premier, iFusion, iVue, iCam, iScan, iStand and Networking. The company was founded by Jay Wei and Tom Zhao in 2003 and is headquartered in Fremont, CA.

Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX.

Carl Zeiss AG engages in the development and manufacture of scientific optics technologies and solutions services. Its products and solutions inlcude medical, microscopy, optemetry, industrial metrology spectroscopy, semicondictor technology, camera and film lenses, and simulation solutions planetariums. The company was founded by Carl Zeiss in 1846 and is headquartered in Oberkochen, Germany.

Laser Diagnostic Technologies, Inc. developed and manufactured diagnostic laser equipment for the eye care industry. The company was headquartered in San Diego, CA.

Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel.

TearSolutions, Inc. develops natural tear generation therapy for dry eyes. The firm's platform technology focuses on the tear protein 'lacritin'? and the proprietary drug 'Lacripep'?. The company was founded by Mark B. Logan, and Gordon W. Laurie in 2013 and is headquartered in Charlottesville, VA.